Serum Institute COVID-19 vaccine gets approval in South Africa

The approval comes amid growing concerns that the 1.5 million vaccine doses to be shipped to South Africa in the next few weeks had not been approved by the local regulator.;

Published On 2021-01-25 06:48 GMT | Update On 2021-01-25 06:48 GMT

Johannesburg: South Africa's health regulatory body has granted approval to the world's largest drug manufacturer Serum Institute of India (SII) to supply COVID-19 vaccine to the country.

Health Minister Zweli Mkhize announced on Friday that the South African Health Products Regulatory Authority (SAHPRA) has granted approval to the SII, which is producing the vaccine in collaboration with the University of Oxford and AstraZeneca, to supply the drug to the country.

The approval comes amid growing concerns that the 1.5 million vaccine doses to be shipped to South Africa in the next few weeks had not been approved by the local regulator.

"We will, in the next coming days, engage with the public in order to give an update on the progress of the first batch of the vaccines that we committed would be received in the first quarter," Mkhize said.

The minister had earlier told the country's parliament that the SII would supply a million doses of the vaccine to South Africa by the end of January and a further 500,000 in February, which would be used to vaccinate front line healthcare workers.

"At this stage we would like to assure South Africans that all is on track. We are working closely with all relevant stakeholders to ensure a smooth implementation of the vaccine roll-out programme," Mkhize said.

South Africa is battling a second wave of the COVID-19 as well as a new variant of the deadly virus.

The country reported 11,761 new COVID-19 cases and 575 deaths in the last 24 hours. With this, the total number of fatalities in the country has reached 40,076.

According to the Johns Hopkins University data, the country has 1,392,568 COVID-19 cases.

The minister said that his department had also been offered vaccines from private agents.

"As a department we have resolved and wish to advise the public that it is critical that any such agent and vaccine authenticity must be verified directly with manufacturers. This is the only way, in our view, to guarantee the quality of the vaccines that may be acquired through third parties," Mkhize said.

Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Serum Institute COVID-19 vaccine gets approval in South Africa

The approval comes amid growing concerns that the 1.5 million vaccine doses to be shipped to South Africa in the next few weeks had not been approved by the local regulator.;

Similar News

Dr Reddy's Labs API Mirfield facility gets 7 USFDA observations

CDSCO Panel Rejects Theon Pharma's Proposal for Empagliflozin, Linagliptin, Metformin FDC

USFDA approves expanded indication for Takeda Vonvendi for adults, children with Von Willebrand Disease

Virchow Biotech Gets CDSCO Panel Nod for Semaglutide BE, Phase III Trials

Industry needs to come forward, take advantage of funds available for MedTech Sector: DoP Joint Secretary

USFDA inspection: Aurobindo Pharma receives 8 observations for Unit-XII

Roche receives EU CE mark for Contivue for neovascular age-related macular degeneration

USFDA issues 4 observations for Zydus Jarod injectable manufacturing plant